Dietary sources of omega 3 fatty acids: Public health risks and benefits

British Journal of Nutrition

Volumn 107, Issue SUPPL. 2, 2012, Pages

  Tur, J A ^a   Bibiloni, M M ^a   Sureda, A ^a   Pons, A ^a  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

Author keywords

Health benefits; Health risks; Omega 3; Public health; Systematic review

Indexed keywords

CANOLA OIL; COD LIVER OIL; CYCLOOXYGENASE 2 INHIBITOR; DOCOSAPENTAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINSEED OIL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHYLMERCURY; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ALGA; ALLERGIC DISEASE; ANTIINFLAMMATORY ACTIVITY; BACKACHE; CANCER RISK; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CONTAMINATED FISH; DIET SUPPLEMENTATION; GERIATRIC NUTRITION; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; KRILL; MATERNAL NUTRITION; NECK PAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL VALUE; OBESITY; PUBLIC HEALTH; REVIEW; RHEUMATOID ARTHRITIS; RISK BENEFIT ANALYSIS; RISK REDUCTION; SEAL; SUDDEN DEATH; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALS; DIET; DIETARY FATS; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FISH OILS; FOOD, FORTIFIED; HUMANS; PLANT OILS; PUBLIC HEALTH; RISK; RISK ASSESSMENT;

ALGAE; ANIMALIA; EUPHAUSIACEA;

EID: 84861130202     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114512001456     Document Type: Review

References (171)

1. EFSA (2009) Opinion of the scientific panel on dietetic products, nutrition and allergies on a request from the Commission related to labeling reference intake values for n-3 and n-6 polyunsaturated fatty acids. EFSA J 1176, 1-11.
2. Kris-Etherton PM, Harris WS, Appel LJ, et al. (2002) Nutrition Committee, Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106, 2747-2757. (Pubitemid 35364932)
3. Kris-Etherton PM, Harris WS, Appel LJ, et al. (2003) Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol 23, 1, 51-152.
4. The World Health Organisation (2003) Diet nutrition and the prevention of chronic diseases. Report of the WHO/FAO Joint Expert Consultation, WHO, Technical Report Series 916
5. Pawlosky RJ, Hibbeln JR, Novotny JA, et al. (2001) Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. J Lipid Res 42, 1257-1265. (Pubitemid 32744249)
6. Arterburn LM, Hall EB & Oken H (2006) Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 83, 1467S-1476S. (Pubitemid 44713087)
7. Lopez-Huertas E (2010) Health effects of oleic acid and long chain omega-3 fatty acids (EPA and DHA) enriched milks. A review of intervention studies. Pharmacol Res 61, 200-207.
8. Neff LM, Culiner J, Cunningham-Rundles S, et al. (2011) Algal docosahexaenoic acid affects plasma lipoprotein particle size distribution in overweight and obese adults. J Nutr 141, 207-213.
9. Geppert J, Kraft V, Demmelmair H, et al. (2006) Microalgal docosahexaenoic acid decreases plasma triacylglycerol in normolipidaemic vegetarians: a randomised trial. Br J Nutr 95, 779-786.
10. Sanders TA, Gleason K, Griffin B, et al. (2006) Influence of an algal triacylglycerol containing docosahexaenoic acid (22 : 6n-3) and docosapentaenoic acid (22 : 5n-6) on cardiovascular risk factors in healthy men and women. Br J Nutr 95, 525-531.
11. Harris WS, Pottala JV, Sands SA, et al. (2007) Comparison of the effects of fish and fish-oil capsules on the n 3 fatty acid content of blood cells and plasma phospholipids. Am J Clin Nutr 86, 1621-1625. (Pubitemid 350232175)
12. Milte CM, Coates AM, Buckley JD, et al. (2008) Dosedependent effects of docosahexaenoic acid-rich fish oil on erythrocyte docosahexaenoic acid and blood lipid levels. Br J Nutr 99, 1083-1088.
13. Peoples GE, McLennan PL, Howe PR, et al. (2008) Fish oil reduces heart rate and oxygen consumption during exercise. J Cardiovasc Pharmacol 52, 540-547.
14. Harrison RA, Sagara M, Rajpura A, et al. (2004) Can foods with added soya-protein or fish-oil reduce risk factors for coronary disease? A factorial randomised controlled trial. Nutr Metab Cardiovasc Dis 14, 344-350. (Pubitemid 40467442)
15. Singer P, Melzer S, Goschel M, et al. (1990) Fish oil amplifies the effect of propranolol in mild essential hypertension. Hypertension 16, 682-691.
16. Din JN, Harding SA, Valerio CJ, et al. (2008) Dietary intervention with oil rich fish reduces platelet-monocyte aggregation in man. Atherosclerosis 197, 290-296. (Pubitemid 351284475)
17. Pirich C, Gaszo A, Granegger S, et al. (1999) Effects of fish oil supplementation on platelet survival and ex vivo platelet function in hypercholesterolemic patients. Thromb Res 96, 219-227. (Pubitemid 29531570)
18. Metcalf RG, James MJ, Gibson RA, et al. (2007) Effects of fish-oil supplementation on myocardial fatty acids in humans. Am J Clin Nutr 85, 1222-1228. (Pubitemid 46740462)
19. Mehra MR, Lavie CJ, Ventura HO, et al. (2006) Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure. J Heart Lung Transplant 25, 834-838. (Pubitemid 43963369)
20. Kaul U, Sanghvi S, Bahl VK, et al. (1992) Fish oil supplements for prevention of restenosis after coronary angioplasty. Int J Cardiol 35, 87-93.
21. Erkkilä AT, Lichtenstein AH, Mozaffarian D, et al. (2004) Fish intake is associated with a reduced progression of coronary artery atherosclerosis in postmenopausal women with coronary artery disease. Am J Clin Nutr 80, 626-632. (Pubitemid 41115527)
22. Seierstad SL, Seljeflot I, Johansen O, et al. (2005) Dietary intake of differently fed salmon; the influence on markers of human atherosclerosis. Eur J Clin Invest 35, 52-59. (Pubitemid 40187954)
23. Ueshima H, Stamler J, Elliott P, et al. (2007) Food omega-3 fatty acid intake of individuals (total, linolenic acid, long-chain) and their blood pressure: INTERMAP study. Hypertension 50, 313-319. (Pubitemid 47205779)
24. Berry JD, Prineas RJ, van Horn L, et al. (2010) Dietary fish intake and incident atrial fibrillation (from the Women's Health Initiative). Am J Cardiol 105, 844-848.
25. Brouwer IA, Zock PL, Camm AJ, et al. (2006) Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. JAMA 295, 2613-2619. (Pubitemid 43882336)
26. Fahs CA, Yan H, Ranadive S, et al. (2010) The effect of acute fish-oil supplementation on endothelial function and arterial stiffness following a high-fat meal. Appl Physiol Nutr Metab 35, 294-302.
27. Poppitt SD, Howe CA, Lithander FE, et al. (2009) Effects of moderate-dose omega-3 fish oil on cardiovascular risk factors and mood after ischemic stroke: a randomized, controlled trial. Stroke 40, 3485-3492.
28. DeGiorgio CM, Miller P, Meymandi S, et al. (2008) n-3 fatty acids (fish oil) for epilepsy, cardiac risk factors, and risk of SUDEP: clues from a pilot, double-blind, exploratory study. Epilepsy Behav 13, 681-684.
29. Watanabe N, Watanabe Y, Kumagai M, et al. (2009) Administration of dietary fish oil capsules in healthy middle-aged Japanese men with a high level of fish consumption. Int J Food Sci Nutr 60, Suppl 5, 136-142.
30. Piolot A, Blache D, Boulet L, et al. (2003) Effect of fish oil on LDL oxidation and plasma homocysteine concentrations in health. J Lab Clin Med 141, 41-49. (Pubitemid 36065085)
31. Mostad IL, Bjerve KS, Lydersen S, et al. (2008) Effects of marine n-3 fatty acid supplementation on lipoprotein subclasses measured by nuclear magnetic resonance in subjects with type II diabetes. Eur J Clin Nutr 62, 419-429. (Pubitemid 351356583)
32. Khandelwal S, Demonty I, Jeemon P, et al. (2009) Independent and interactive effects of plant sterols and fish oil n-3 long-chain polyunsaturated fatty acids on the plasma lipid profile of mildly hyperlipidaemic Indian adults. Br J Nutr 102, 722-732.
33. Feskens EJ, Virtanen SM, Rasanen L, et al. (1995) Dietary factors determining diabetes and impaired glucose tolerance. A 20-year follow-up of the Finnish and Dutch cohorts of the Seven Countries Study. Diabetes Care 18, 1104-1112.
34. Patel PS, Sharp SJ, Luben RN, et al. (2009) Association between type of dietary fish and seafood intake and the risk of incident type 2 diabetes: the European prospective investigation of cancer (EPIC)-Norfolk cohort study. Diabetes Care 32, 1857-1863.
35. Feskens EJ, Bowles CH & Kromhout D (1991) Inverse association between fish intake and risk of glucose intolerance in normoglycemic elderly men and women. Diabetes Care 14, 935-941.
36. Kaushik M, Mozaffarian D, Spiegelman D, et al. (2009) Long chain omega-3 fatty acids, fish intake, and the risk of type 2 diabetes mellitus. Am J Clin Nutr 90, 613-620.
37. Friday KE, Childs MT, Tsunehara CH, et al. (1989) Elevated plasma glucose and lowered triglyceride levels from omega-3 fatty acid supplementation in type II diabetes. Diabetes Care 12, 276-281. (Pubitemid 19092238)
38. Rivellese AA, Maffettone A, Iovine C, et al. (1996) Longterm effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia. Diabetes Care 19, 1207-1213.
39. Luo J, Rizkalla SW, Vidal H, et al. (1998) Moderate intake of n-3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men. Results of a controlled study. Diabetes Care 21, 717-724. (Pubitemid 28487061)
40. Borkman M, Chisholm DJ, Furler SM, et al. (1989) Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM. Diabetes 38, 1314-1319. (Pubitemid 19247429)
41. Djoussé L, Gaziano JM, Buring JE, et al. (2011) Dietary omega-3 fatty acids and fish consumption and risk of type 2 diabetes. Am J Clin Nutr 93, 143-150.
42. Belalcazar LM, Reboussin DM, Haffner SM, et al. (2010) Marine omega-3 fatty acid intake: associations with cardiometabolic risk and response to weight loss intervention in the Look AHEAD Study. Diabetes Care 33, 197-199.
43. Giacco R, Cuomo V, Vessby B, et al. (2007) Fish oil, insulin sensitivity, insulin secretion and glucose tolerance in healthy people: is there any effect of fish oil supplementation in relation to the type of background diet and habitual dietary intake of n-6 and n-3 fatty acids? Nutr Metab Cardiovasc Dis 17, 572-580. (Pubitemid 47302305)
44. Mostad IL, Bjerve KS, Basu S, et al. (2009) Addition of n-3 fatty acids to a 4-hour lipid infusion does not affect insulin sensitivity, insulin secretion, or markers of oxidative stress in subjects with type 2 diabetes mellitus. Metabolism 58, 1753-1761.
45. Navas-Carretero S, Pérez-Granados AM, Schoppen S, et al. (2009) An oily fish diet increases insulin sensitivity compared to a red meat diet in young iron-deficient women. Br J Nutr 102, 546-553.
46. Kew S, Mesa MD, Tricon S, et al. (2004) Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on immune cell composition and function in healthy humans. Am J Clin Nutr 79, 674-681. (Pubitemid 41103914)
47. Ramel A, Martinez JA, Kiely M, et al. (2010) Effects of weight loss and seafood consumption on inflammation parameters in young, overweight and obese European men and women during 8 weeks of energy restriction. Eur J Clin Nutr 64, 987-993.
48. Ramel A, Martinez JA, Kiely M, et al. (2010) Moderate consumption of fatty fish reduces diastolic blood pressure in overweight and obese European young adults during energy restriction. Nutrition 26, 168-174.
49. Zhang J, Wang C, Li L, et al. (2010) Inclusion of Atlantic salmon in the Chinese diet reduces cardiovascular disease risk markers in dyslipidemic adult men. Nutr Res 30, 447-454.
50. Mickleborough TD, Murray RL, Ionescu AA, et al. (2003) Fish oil supplementation reduces severity of exerciseinduced bronchoconstriction in elite athletes. Am J Respir Crit Care Med 168, 1181-1189. (Pubitemid 37421835)
51. Bowden RG, Wilson RL, Deike E, et al. (2009) Fish oil supplementation lowers C-reactive protein levels independent of triglyceride reduction in patients with end-stage renal disease. Nutr Clin Prac 24, 508-512.
52. Lankinen M, Schwab U, Erkkilä A, et al. (2009) Fatty fish intake decreases lipids related to inflammation and insulin signalling: a lipidomics approach. PLoS One 4, e5258.
53. Lopez-Garcia E, Schulze MB, Manson JE, et al. (2004) Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 134, 1806-1811. (Pubitemid 38886573)
54. Xiong J, Zhu S, Zhou Y, et al. (2009) Regulation of omega-3 fish oil emulsion on the SIRS during the initial stage of severe acute pancreatitis. J Huazhong Univ Sci Technolog Med Sci 29, 35-38.
55. Lau CS, Morley KD & Belch JJ (1993) Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis-a double-blind placebo controlled study. Br J Rheumatol 32, 982-989. (Pubitemid 23334899)
56. Maroon JC & Bost JW (2006) Omega-3 fatty acids (fish oil) as an anti-inflammatory: an alternative to nonsteroidal antiinflammatory drugs for discogenic pain. Surg Neurol 65, 326-331. (Pubitemid 43384072)
57. Galarraga B, Ho M, Youssef HM, et al. (2008) Cod liver oil (n-3 fatty acids) as an non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis. Rheumatology (Oxford) 47, 665-669. (Pubitemid 351619210)
58. Caughey GE, James MJ, Proudman SM, et al. (2010) Fish oil supplementation increases the cyclooxygenase inhibitory activity of paracetamol in rheumatoid arthritis patients. Complement Ther Med 18, 171-174.
59. Dry J & Vincent D (1991) Effect of a fish oil diet on asthma: results of a 1-year double-blind study. Int Arch Allergy Appl Immunol 95, 156-157.
60. Pot GK, Brouwer IA, Enneman A, et al. (2009) No effect of fish oil supplementation on serum inflammatory markers and their interrelationships: a randomized controlled trial in healthy, middle-aged individuals. Eur J Clin Nutr 63, 1353-1359.
61. Michaeli B, Berger MM, Revelly JP, et al. (2007) Effects of fish oil on the neuro-endocrine responses to an endotoxin challenge in healthy volunteers. Clin Nutr 26, 70-77. (Pubitemid 46179108)
62. Bouwens M, van de Rest O, Dellschaft N, et al. (2009) Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells. Am J Clin Nutr 90, 415-424.
63. Moghadamnia AA, Mirhosseini N, Abadi MH, et al. (2010) Effect of Clupeonella grimmi (anchovy/kilka) fish oil on dysmenorrhoea. East Mediterr Health J 16, 408-413.
64. Franke C, Demmelmair H, Decsi T, et al. (2010) Influence of fish oil or folate supplementation on the time course of plasma redox markers during pregnancy. Br J Nutr 103, 1648-1656.
65. Dunstan JA, Simmer K, Dixon G, et al. (2008) Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomized controlled trial. Arch Dis Child Fetal Neonatal Ed 93, F45-F50.
66. Schnappinger M, Sausenthaler S, Linseisen J, et al. (2009) Fish consumption, allergic sensitization and allergic diseases in adults. Ann Nutr Metab 54, 67-74.
67. Prescott SL, Barden AE, Mori TA, et al. (2007) Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord-blood-derived neutrophils. Clin Sci (Lond) 113, 409-416. (Pubitemid 350144375)
68. Smithers LG, Markrides M & Gibson RA (2010) Human milk fatty acids from lactating mothers of preterm infants: a study revealing wide intra-and inter-individual variation. Prostaglandins Leukot Essent Fatty Acids 83, 9-13.
69. Furuhjelm C, Warstedt K, Larsson J, et al. (2009) Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatr 98, 1461-1467.
70. Lauritzen L, Christensen JH, Damsgaard CT, et al. (2008) The effect of fish oil supplementation on heart rate in healthy Danish infants. Pediatr Res 64, 610-614.
71. Fortier M, Tremblay-Mercier J, Plourde M, et al. (2010) Higher plasma n-3 fatty acid status in the moderately healthy elderly in southern Québec: higher fish intake or aging-related change in n-3 fatty acid metabolism? Prostaglandins Leukot Essent Fatty Acids 82, 277-280.
72. van de Rest O, Geleijnse JM, Kok FJ, et al. (2008) Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial. Neurology 71, 430-438.
73. van de Rest O, Geleijnse JM, Kok FJ, et al. (2009) Effect of fish oil supplementation on quality of life in a general population of older Dutch subjects: a randomized, double-blind, placebo-controlled trial. J Am Geriatr Soc 57, 1481-1486.
74. Astorg P, Couthouis A, Bertrais S, et al. (2008) Association of fish and long-chain n-3 polyunsaturated fatty acid intakes with the occurrence of depressive episodes in middleaged French men and women. Prostaglandins Leukot Essent Fatty Acids 78, 171-182. (Pubitemid 351522825)
75. Ramel A, Parra D, Martinez JA, et al. (2009) Effects of seafood consumption and weight loss on fasting leptin and ghrelin concentrations in overweight and obese European young adults. Eur J Nutr 48, 107-114.
76. van de Rest O, Geleijnse JM, Kok FJ, et al. (2008) Effect of fish-oil supplementation on mental well-being in older subjects: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 88, 706-713.
77. Augood C, Chakravarthy U, Young I, et al. (2008) Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular agerelated macular degeneration. Am J Clin Nutr 88, 398-406.
78. Mori TA, Bao DQ, Burke V, et al. (1999) Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. Am J Clin Nutr 70, 817-825. (Pubitemid 29512906)
79. Gunnarsdottir I, Tomasson H, Kiely M, et al. (2008) Inclusion of fish or fish oil in weight-loss diets for young adults: effects on blood lipids. Int J Obes (Lond) 32, 1105-1112. (Pubitemid 351986209)
80. Parra D, Ramel A, Bandarra N, et al. (2008) A diet rich in long chain omega-3 fatty acids modulates satiety in overweight and obese volunteers during weight loss. Appetite 51, 676-680.
81. Kratz M, Callahan HS, Yang PY, et al. (2009) Dietary n-3-polyunsaturated fatty acids and energy balance in overweight or moderately obese men and women: a randomized controlled trial. Nutr Metabol 6, 7.
82. Rhodes LE, Durham BH, Fraser WD, et al. (1995) Dietary fish oil reduces basal and ultraviolet B-generated PGE2 levels in skin and increases the threshold to provocation of polymorphic light eruption. J Invest Dermatol 105, 532-535.
83. Thusgaard M, Christensen JH, Mørn B, et al. (2009) Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: a randomized, double-blind, placebo-controlled study. Scand J Infect Dis 41, 760-766.
84. Engeset D, Alsaker E, Lund E, et al. (2006) Fish consumption and breast cancer risk. The European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 119, 175-182.
85. van der Meij BS, Langius JA, Smit EF, et al. (2010) Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment. J Nutr 140, 1774-1780.
86. Cerchietti LC, Navigante AH & Castro MA (2007) Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer. Nutr Cancer 59, 14-20. (Pubitemid 47549776)
87. Barber MD, Ross JA, Voss AC, et al. (1999) The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer 81, 80-86. (Pubitemid 29415495)
88. Leitzmann MF, Stampfer MJ, Michaud DS, et al. (2004) Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer. Am J Clin Nutr 80, 204-216.
89. Mozaffarian D (2006) Fish Intake, Contaminants, and Human Health: Evaluating the Risks and the Benefits Part 2-Health Risks and Optimal Intakes. Cardiol Rounds 10, 1-6.
90. U.S. Environmental Protection AgencyMercury Study Report to Congress Available: http://www.epa.gov/mercury/report.htm (accessed May 2011)
91. Jeejeebhoy KN (2008) Benefits and risks of a fish diet-should we be eating more or less? Nature Clin Pract 5, 178-179. (Pubitemid 351516729)
92. Harris HH, Pickering IJ & George GN (2003) The chemical form of mercury in fish. Science 302, 1203. (Pubitemid 37052201)
93. Committee on the Toxicological Effects of Methylmercury (2000) Board on Environmental Studies and Toxicology; Commission on Life Sciences; National Research Council. Toxicological Effects of Methylmercury. Washington, DC: National Academy Press.
94. Gochfeld M (2003) Cases of mercury exposure, bioavailability, and absorption. Ecotoxicol Environ Saf 56, 174-179. (Pubitemid 36962794)
95. U.S. EPA (U.S. Environmental Protection Agency) (2001) Methylmercury (MeHg) (CASRN 22967-92-6). Available: http://www.epa.gov/iris/subst/0073.htm (accessed May 2011)
96. Ginsberg GL & Toal BF (2009) Quantitative approach for incorporating methylmercury risks and omega-3 fatty acid benefits in developing species-specific fish consumption advice. Environ Health Persp 117, 267-275.
97. McDowell MA, Dillon CF, Osterloh J, et al. (2004) Hair mercury levels in U.S. children and women of childbearing age: reference range data from NHANES 1999-2000. Environ Health Perspect 112, 1165-1171. (Pubitemid 39157617)
98. Grandjean P, Weihe P, White RF, et al. (1997) Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol 19, 417-428. (Pubitemid 27489345)
99. Grandjean P, Weihe P, White RF & Debes F (1998) Cognitive performance of children prenatally exposed to "safe" levels of methylmercury. Environ Res 77, 165-172. (Pubitemid 28243891)
100. Kjellstrom T (1989) Physical and mental development of children with prenatal exposure to mercury from fish. Stage II: interviews and psychological tests at age 6. Stockholm, Sweden: National Swedish Environmental Protection Board; Report 3642. Solna, Sweden: National Swedish Environmental Protection Board.
101. Crump KS, Kjellstrom T, Shipp AM, et al. (1998) Influence of prenatal mercury exposure upon scholastic and psychological test performance: benchmark analysis of a New Zealand cohort. Risk Anal 18, 701-713.
102. Jedrychowski W, Jankowski J, Flak E, et al. (2006) Effects of prenatal exposure to mercury on cognitive and psychomotor function in one-year-old infants: Epidemiologic Cohort Study in Poland. Ann Epidemiol 16, 439-447. (Pubitemid 43744457)
103. Davidson PW, Palumbo D, Myers GJ, et al. (2000) Neurodevelopmental outcomes of Seychellois children from the pilot cohort at 108 months following prenatal exposure to methylmercury from a maternal fish diet. Environ Res 84, 1-11.
104. Palumbo DR, Cox C, Davidson PW, et al. (2000) Association between prenatal exposure to methylmercury and cognitive functioning in Seychellois children: a reanalysis of the McCarthy Scales of Children's Ability from the main cohort study. Environ Res 84, 81-88.
105. Oken E, Wright RO, Kleinman KP, et al. (2005) Maternal fish consumption, hair mercury, and infant cognition in a U.S. Cohort. Environ Health Perspect 113, 1376-1380. (Pubitemid 41511996)
106. Daniels JL, Longnecker MP, Rowland AS, et al. (2004) Fish intake during pregnancy and early cognitive development of offspring. Epidemiology 15, 394-402. (Pubitemid 40416926)
107. FDA (Food and Drug Administration) (2004) Press Release: FDA and EPA Announce the Revised Consumer Advisory on Methylmercury in Fish, March 19, 2004. Available: http://www.fda.gov/bbs/topics/news/2004/NEW01038.html (accessed May 2011)
108. FDA (2005) Letter Regarding Eggs with Enhanced Omega-3 Fatty Acid Content and a Balanced Ratio of Omega-3/Omega-6 Fatty Acids and Reduced Risk of Heart Disease and Sudden Fatal Heart Attack (Docket No. 2004Q-0072). Available: http://www.cfsan.fda.gov/,dms/qhceggs.html (accessed May 2011)
109. FDA (2006) Mercury Levels in Commercial Fish and Shellfish. Available: http://www.cfsan.fda.gov/,frf/sea-mehg. html (accessed May 2011).
110. USDA (2005) Addendum A: EPA and DHA Content of Fish Species. Available: http://www.health.gov/dietaryguidelines/dga2005/report/HTML/table-g2-adda2.htm (accessed May 2011).
111. U.S. EPA (U.S. Environmental Protection Agency) (1995) IRIS file for Mercuric Chloride. Available: http://www.epa. gov/ncea/iris/subst/0692.htm (accessed May 2011).
112. U.S. EPA (U.S. Environmental Protection Agency) (2004) What You Need to Know about Mercury in Fish and Shellfish. Available: http://www.epa.gov/ waterscience/fishadvice/advice.html (accessed May 2011).
113. Rice DC (2004) The US EPA reference dose for methylmercury: sources of uncertainty. Environ Res 95, 406-413. (Pubitemid 38833592)
114. Rissanen T, Voutilainen S, Nyyssonen K, et al. (2000) Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events: the Kuopio ischaemic heart disease risk factor study. Circulation 102, 2677-2679.
115. Guallar E, Sanz-Gallardo MI, van't Veer P, et al. (2002) Mercury, fish oils, and the risk of myocardial infarction. N Engl J Med 347, 1747-1754. (Pubitemid 35375613)
116. Virtanen JK, Voutilainen S, Rissanen TH, et al. (2005) Mercury, fish oils, and risk of acute coronary events and cardiovascular disease, coronary heart disease, and allcause mortality in men in eastern Finland. Arterioscler Thromb Vasc Biol 25, 228-233. (Pubitemid 40054281)
117. Risher JF, Murray HE & Prince GR (2002) Organic mercury compounds: human exposure and its relevance to public health. Toxicol Ind Health 18, 109-160. (Pubitemid 37082204)
118. He K, Song Y, Daviglus ML, et al. (2004) Fish consumption and incidence of stroke: a meta-analysis of cohort studies. Stroke 35, 1538-1542. (Pubitemid 38823619)
119. Morris MC, Evans DA, Tangney CC, et al. (2005) Fish consumption and cognitive decline with age in a large community study. Arch Neurol 62, 1849-1853. (Pubitemid 41785078)
120. Peet M & Stokes C (2005) Omega-3 fatty acids in the treatment of psychiatric disorders. Drugs 65, 1051-1059. (Pubitemid 40840003)
121. Young G & Conquer J (2005) Omega-3 fatty acids and neuropsychiatric disorders. Reprod Nutr Dev 45, 1-28. (Pubitemid 40528530)
122. Mozaffarian D & Rimm EB (2006) Fish intake, contaminants, and human health evaluating the risks and the benefits. JAMA 296, 1885-1899. (Pubitemid 44596197)
123. Kaul N, Kreml R, Austria JA, et al. (2008) A comparison of fish oil, flaxseed oil and hempseed oil supplementation on selected parameters of cardiovascular health in healthy volunteers. J Am Coll Nutr 27, 51-58. (Pubitemid 351600522)
124. Egert S, Kannenberg F, Somoza V, et al. (2009) Dietary alpha-linolenic acid, EPA, and DHA have differential effects on LDL fatty acid composition but similar effects on serum lipid profiles in normolipidemic humans. J Nutr 139, 861-868.
125. Barceló-Coblijn G, Murphy EJ, Othman R, et al. (2008) Flaxseed oil and fish-oil capsule consumption alters human red blood cell n-3 fatty acid composition: a multiple-dosing trial comparing 2 sources of n-3 fatty acid. Am J Clin Nutr 88, 801-809.
126. Sioen I, Hacquebard M, Hick G, et al. (2009) Effect of ALA-enriched food supply on cardiovascular risk factors in males. Lipids 44, 603-611.
127. Bloedon LT, Balikai S, Chittams J, et al. (2008) Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trial. J Am Coll Nutr 27, 65-74. (Pubitemid 351600524)
128. Dodin S, Cunnane SC, Mâsse B, et al. (2008) Flaxseed on cardiovascular disease markers in healthy menopausal women: a randomized, double-blind, placebo-controlled trial. Nutrition 24, 23-30. (Pubitemid 350225655)
129. Campos H, Baylin A & Willett WC (2008) Alpha-linolenic acid and risk of nonfatal acute myocardial infarction. Circulation 118, 339-345.
130. Yamagishi K, Nettleton JA, Folsom AR & ARIC Study Investigators (2008) Plasma fatty acid composition and incident heart failure in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 156, 965-974.
131. Warensjö E, Sundström J, Vessby B, et al. (2008) Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: a population-based prospective study. Am J Clin Nutr 88, 203-209. (Pubitemid 351988700)
132. Park Y, Park S, Yi H, et al. (2009) Low level of n-3 polyunsaturated fatty acids in erythrocytes is a risk factor for both acute ischemic and hemorrhagic stroke in Koreans. Nutr Res 29, 825-830.
133. Virtanen JK, Mursu J, Voutilainen S, et al. (2009) Serum long-chain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men. Circulation 120, 2315-2321.
134. Lemaitre RN, King IB, Sotoodehnia N, et al. (2009) Red blood cell membrane alpha-linolenic acid and the risk of sudden cardiac arrest. Metabolism 58, 534-540.
135. Finnegan YE, Minihane AM, Leigh-Firbank EC, et al. (2003) Plant-and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects. Am J Clin Nutr 77, 783-795.
136. Malgeunsinae Kim, Jung Hyun Nam, Dong Hoon Oh, et al. (2010) Erythrocyte alpha-linolenic acid is associated with the risk for mild dementia in Korean elderly. Nutr Res 30, 756-761.
137. Griel AE, Kris-Etherton PM, Hilpert KF, et al. (2007) An increase in dietary n-3 fatty acids decreases a marker of bone resorption in humans. Nutr J 6, 2.
138. Taylor CG, Noto AD, Stringer DM, et al. (2010) Dietary milled flaxseed and flaxseed oil improve N-3 fatty acid status and do not affect glycemic control in individuals with well-controlled type 2 diabetes. J Am Coll Nutr 29, 72-80.
139. Paschos GK, Magkos F, Panagiotakos DB, et al. (2007) Dietary supplementation with flaxseed oil lowers blood pressure in dyslipidaemic patients. Eur J Clin Nutr 61, 1201-1206. (Pubitemid 47521552)
140. Paschos GK, Zampelas A, Panagiotakos DB, et al. (2007) Effects of flaxseed oil supplementation on plasma adiponectin levels in dyslipidemic men. Eur J Clin Nutr 46, 315-320. (Pubitemid 47353605)
141. Harper CR, Edwards MC & Jacobson TA (2007) Flaxseed oil supplementation does not affect plasma lipoprotein concentration or particle size in human subjects. J Nutr 136, 2844-2848. (Pubitemid 44771784)
142. Cunnane SC, Hamadeh MJ, Liede AC, et al. (1995) Nutritional attributes of traditional flaxseed in healthy young adults. Am J Clin Nutr 61, 62-68.
143. Kew S, Banerjee T, Minihane AM, et al. (2003) Lack of effect of foods enriched with plant-or marine-derived n-3 fatty acids on human immune function. Am J Clin Nutr 77, 1287-1295. (Pubitemid 44858448)
144. Hoffman D, Ziegler E, Mitmesser SH, et al. (2008) Soybased infant formula supplemented with DHA and ARA supports growth and increases circulating levels of these fatty acids in infants. Lipids 43, 29-35. (Pubitemid 351206958)
145. Egert S, Somoza V, Kannenberg F, et al. (2007) Influence of three rapeseed oil-rich diets, fortified with alpha-linolenic acid, eicosapentaenoic acid or docosahexaenoic acid on the composition and oxidizability of low-density lipoproteins: results of a controlled study in healthy volunteers. Eur J Clin Nutr 61, 314-325. (Pubitemid 46358770)
146. Visioli F, Rise P, Plasmati E, et al. (2000) Very low intakes of n-3 fatty acids incorporated into bovine milk reduce plasma triacylglycerols and increase HDL-cholesterol concentrations in healthy subjects. Pharmacol Res 41, 571-576.
147. Baró L, Fonollá J, Peña JL, et al. (2003) n-3 fatty
148. Carrero JJ, Baró L, Fonollá J, et al. (2004) Cardiovascular effects of milk enriched with n-3 polyunsaturated fatty acids, oleic acid folic acid and vitamins E, B6 and B12 in volunteers with mild hyperlipidaemia. Nutrition 20, 521-527. (Pubitemid 38692494)
149. Dawczynski C, Martin L, Wagner A, et al. (2010) n-3 LCPUFAs-enriched dairy products are able to reduce cardiovascular risk factors: a double-blind, cross-over study. Clin Nutr 29, 592-599.
150. Chong MF, Lockyer S, Saunders CJ, et al. (2010) Long chain n-3 PUFA-rich meal reduced postprandial measures of arterial stiffness. Clin Nutr 29, 678-681.
151. Estévez-González MD, Saavedra-Santana P & Betancor-León P (1998) Reduction of serum cholesterol and low-density lipoprotein cholesterol levels in a juvenile population after isocaloric substitution of whole milk with a milk preparation (skimmed milk enriched with oleic acid). J Pediatr 132, 85-89. (Pubitemid 28082537)
152. Cobiac L, Clifton PM, Abbey M, et al. (1991) Lipid, lipoprotein, and hemostatic effects of fish vs fish-oil n-3 fatty acids in mildly hyperlipidemic males. Am J Clin Nutr 53, 1210-1216.
153. Fonollá J, López-Huertas E, Machado FJ, et al. (2009) Milk enriched with "healthy fatty acids" improves cardiovascular risk markers and nutritional status in human volunteers. Nutrition 25, 408-414.
154. Carrero JJ, López-Huertas E, Salmerón LM, et al. (2005) Daily supplementation with (n-3) PUFAs, oleic acid, folic acid, and vitamins B-6 and E increases pain free walking distance and improves risk factors in men with peripheral vascular disease. J Nutr 135, 1393-1399. (Pubitemid 40799601)
155. Carrero JJ, Fonollá J, Marti JL, et al. (2007) Intake of fish oil, oleic acid, folic acid, and vitamins B-6 and E for 1 year decreases plasma C reactive protein and reduces coronary heart disease risk factors in male patients in a cardiac rehabilitation program. J Nutr 137, 384-390. (Pubitemid 46213454)
156. Benito P, Caballero J, Moreno J, et al. (2006) Effects of milk enriched with omega-3 fatty acid, oleic acid and folic acid in patients with metabolic syndrome. Clin Nutr 25, 581-587. (Pubitemid 44070584)
157. Givens DI & Gibbs RA (2008) Current intakes of EPA and DHA in European populations and the potential of animal-derived foods to increase them. Proc Nutr Soc 67, 273-280.
158. Kronberg SL, Barcelo-Coblijn G, Shin J, et al. (2006) Bovine muscle n-3 fatty acid content is increased with flaxseed feeding. Lipids 41, 1059-1068. (Pubitemid 46047982)
159. Kjos NP, Skrede A & Overland M (1999) Effects of dietary fish silage and fish fat on growth performance and sensory quality of growing-finishing pigs. Can J Anim Sci 79, 139-147. (Pubitemid 129341984)
160. Jaturasitha S, Khiaosa-ard R, Pongpiachan P, et al. (2009) Early deposition of n-3 fatty acids from tuna oil in lean and adipose tissue of fattening pigs is mainly permanent. J Anim Sci 87, 693-703.
161. Muench S & Watzl B (2010) Incorporation of ingredients rich in omega-3 fatty acids into functional meat products. Mitteil Fleischf Kulmb 49, 39-48.
162. Cachaldora P, Garcia-Rebollar P & Alvarez C (2009) Double enrichment of chicken eggs with conjugated linoleic acid and n-3 fatty acids through dietary fat supplementation. Animal Feed Sci Tech 144, 315-326. (Pubitemid 351863751)
163. Bovet P, Faeh D, Madeleine G, et al. (2007) Decrease in blood triglycerides associated with the consumption of eggs of hens fed with food supplemented with fish oil. Nutr Metab Cardiovasc Dis 17, 280-287. (Pubitemid 46551686)
164. Rizzi L, Bochicchio D & Bargellini A (2009) Effects of dietary microalgae, other lipid sources, inorganic selenium and iodine on yolk n-3 fatty acid composition, selenium content and quality of eggs in laying hens. J Sci Food Agric 89, 1775-1781.
165. Bourre JM (2005) Where to find omega-3 fatty acids and how feeding animals with diet enriched in omega-3 fatty acids to increase nutritional value of derived products for human: what is actually useful? J Nutr Health Aging 9, 232-242.
166. Tou JC, Jaczynski J & Chen YC (2007) Krill for human consumption: nutritional value and potential health benefits. Nutr Rev 65, 63-77. (Pubitemid 351804381)
167. Maki KC, Reeves MS, Farmer M, et al. (2009) Krill oil supplementation increases plasma concentrations of eicosapentaenoic and docosahexaenoic acids in overweight and obese men and women. Nutr Res 29, 609-615.
168. Bunea R, El Farrah K & Deutsch L (2004) Evaluation of the effects of Neptune Krill Oil on the clinical course of hyperlipidemia. Altern Med Rev 9, 420-428. (Pubitemid 40066715)
169. Sampalis F, Bunea R, Pelland MF, et al. (2003) Evaluation of the effects of Neptune Krill Oil on the management of premenstrual syndrome and dysmenorrheal. Altern Med Rev 8, 171-179. (Pubitemid 36676184)
170. Conquer JA, Cheryk LA, Chan E, et al. (1999) Effect of supplementation with dietary seal oil on selected cardiovascular risk factors and hemostatic variables in healthy male subjects. Thromb Res 96, 239-250. (Pubitemid 29531572)
171. Zhu FS, Liu S, Chen XM, et al. (2008) Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia. World J Gastroenterol 14, 6395-6400.